Hsiao-Hwa Lu

Title: Hsiao-Hwa Lu: Innovator in Pharmaceutical Chemistry

Introduction

Hsiao-Hwa Lu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, his work focuses on addressing critical health issues.

Latest Patents

Among his latest patents, Hsiao-Hwa Lu has developed "Angiotensin II receptor antagonistic 1,2,4-triazin-5-one derivatives." This patent discloses novel 1,2,4-triazin-5-one biphenyl derivatives that serve as non-peptide antagonists of the angiotensin II receptor. The structural formula includes various substituents, where R1 represents alkyl, cycloalkyl, or substituted or unsubstituted aryl. Another significant patent is for "Di- and tri-peptide mimetic compounds for Parkinson's disease." This series of compounds includes di- and tri-peptide mimetic dopamine prodrugs, which are synthesized to facilitate the delivery of L-dopa through the intestine, utilizing the intestinal dipeptide-mediated carrier transport system. These compounds are found to be useful as active ingredients for the treatment of Parkinson's disease.

Career Highlights

Hsiao-Hwa Lu has worked with notable organizations, including the Department of Health, Executive Yuan, Republic of China, and the Development Center for Biotechnology. His experience in these institutions has allowed him to contribute to significant advancements in healthcare and biotechnology.

Collaborations

Hsiao-Hwa Lu has collaborated with several professionals in his field, including Hui-po Wang and Jia-Shuai Lee. These collaborations have further enhanced his research and development efforts.

Conclusion

Hsiao-Hwa Lu's innovative work in pharmaceutical chemistry has led to the development of important compounds that address significant health challenges. His contributions continue to impact the field positively.